Derivation and characterization of the human embryonic stem cell line CR-4: Differentiation to human retinal pigment epithelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Derivation and characterization of the human embryonic stem cell line CR-4: Differentiation to human retinal pigment epithelial cells

Published:2017-01 Issue: Volume:18 Page:37-40
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Mazzilli John L.,Domozhirov Aleksey Y.,Mueller-Ortiz Stacey L.,Garcia Charles A.,Wetsel Rick A.,Zsigmond Eva M.

Funder

The University of Texas Health Science Center at Houston

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference4 articles.

1. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics;Klimanskaya;Cloning Stem Cells,2004

2. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients;Song;Stem Cell Rep.,2015

3. Stem cells for retinal repair;Stern,2014

4. Embryonic stem cell lines derived from human blastocysts;Thomson;Science,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking for In Vitro Models for Retinal Diseases;International Journal of Molecular Sciences;2021-09-25

2. Stem Cell Therapy for Ophthalmic Vascular Disease;Stem Cell Therapy for Vascular Diseases;2020-11-06

3. Recent theranostic paradigms for the management of Age-related macular degeneration;European Journal of Pharmaceutical Sciences;2020-10

4. Complement Receptor 1 (CR1/CD35)-expressing retinal pigment epithelial cells as a potential therapy for age-related macular degeneration;Molecular Immunology;2020-02

5. A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration;Journal of Ocular Pharmacology and Therapeutics;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3